Source: Drug Channels

CoverMyMeds: Clear Connections for Equitable Medication Access

Today's guest post comes from John Beardsley, Senior Vice President of Corporate Strategy at CoverMyMeds.John discusses some of the findings in CoverMyMeds' recently published report on medication access. He describes patient-centric, data-driven solutions to help patients access, afford, and adhere to their therapies.To learn more, download CoverMyMeds' 2022 Medication Access Report.Read on for John's insights.Read more »Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Matt Scantland's photo - Co-Founder & CEO of CoverMyMeds

Co-Founder & CEO

Matt Scantland

CEO Approval Rating

74/100

Read more